Publications by authors named "Trupti Sawant"
Aim: We aimed to identify and describe the unmet needs of patients with multidrug-resistant tuberculosis (MDR-TB).
Methods: As a part of larger cross-sectional mixed-methods (qualitative and quantitative data) study on pathways to MDR-TB care, here we present the qualitative component. We interviewed 128 (56 men and 72 women) individuals who had MDR-TB, aged > = 15 years, registered and treated under the National TB Elimination Program (NTEP) in Pune city of India.
Earlier biomarkers of pulmonary tuberculosis (PTB) treatment outcomes are critical to monitor shortened anti-TB treatment (ATT). To identify early microbiologic markers of unfavorable TB treatment outcomes. We performed a subanalysis of 2 prospective TB cohort studies conducted from 2013 to 2019 in India.
View Article and Find Full Text PDFBackground: Approximately 7% of all reported tuberculosis (TB) cases each year are recurrent, occurring among people who have had TB in the recent or distant past. TB recurrence is particularly common in India, which has the largest TB burden worldwide. Although patients recently treated for TB are at high risk of developing TB again, evidence around effective active case finding (ACF) strategies in this population is scarce.
View Article and Find Full Text PDFArticle Synopsis
- The study investigates private practitioners' (PPs) experiences with TB notification in Maharashtra, India, following the government's 2012 policy mandating TB case reporting.
- A survey of 200 PPs revealed that while 97% were aware of the notification requirement, the majority (89%) preferred paper-based methods over electronic ones due to familiarity and technical issues.
- The findings suggest the need for the National TB Elimination Program (NTEP) to enhance training and support for PPs, including increasing awareness of electronic notification systems and clarifying the process for receiving monetary incentives.
Tuberculosis Pathways to Care and Transmission of Multidrug Resistance in India.
Am J Respir Crit Care Med
January 2022
India is experiencing a regional increase in cases of multidrug-resistant tuberculosis (MDR-TB). Given the complexity of MDR-TB diagnosis and care, we sought to address key knowledge gaps in MDR risk factors, care delays, and drivers of delay to help guide disease control. From January 2018 to September 2019, we conducted interviews with adults registered with the National TB Elimination Program for MDR ( = 128) and non-MDR-TB ( = 269) treatment to quantitatively and qualitatively study care pathways.
View Article and Find Full Text PDF